lexiara

g.

‘Precursors’, as follows: NB:In ML8.g. the references are to controlled ‘Energetic Materials’ manufactured from these substances. BCMO (bischloromethyloxetane) (CAS 142173-26-0) (see also ML8.e.1. and e.2.); Dinitroazetidine-t-butyl salt (CAS 125735-38-8) (see also ML8.a.28.); HBIW (hexabenzylhexaazaisowurtzitane) (CAS 124782-15-6) (see also ML8.a.4.); TAIW (tetraacetyldibenzylhexaazaisowurtzitane) (see also ML8.a.4.); TAT (1.3,5,7 tetraacetyl-1.3,5.7,-tetraaza cyclo-octane) (CAS 41378-98-7) (see also ML8.a.13.); 1.4,5,8-tetraazadecalin (CAS 5409-42-7) (see also ML8.a.27.); 1.3,5-trichlorobenzene (CAS 108-70-3) (see also ML8.a.23.); 1.2,4-trihydroxybutane (1.2,4-butanetriol) (CAS 3068-00-6) (see also L8.e.5.).

· All articles ·

Source: EUR-Lex (Cellar) · retrieved 2026-11-05 · Text as adopted (Official Journal); later amendments are not incorporated in this text.